159 related articles for article (PubMed ID: 34542400)
21. Subependymal Giant Cell Astrocytoma Tumors in Patients Without Clinical Manifestation of Tuberous Sclerosis Complex: A Diagnostic Puzzle.
Zabielska B; Rzewuska N; Jóźwiak S
Pediatr Neurol; 2024 Jan; 150():40-42. PubMed ID: 37951161
[No Abstract] [Full Text] [Related]
22. Everolimus tablets for patients with subependymal giant cell astrocytoma.
Turner SG; Peters KB; Vredenburgh JJ; Desjardins A; Friedman HS; Reardon DA
Expert Opin Pharmacother; 2011 Oct; 12(14):2265-9. PubMed ID: 21806479
[TBL] [Abstract][Full Text] [Related]
23. A case of solitary subependymal giant cell astrocytoma: two somatic hits of TSC2 in the tumor, without evidence of somatic mosaicism.
Ichikawa T; Wakisaka A; Daido S; Takao S; Tamiya T; Date I; Koizumi S; Niida Y
J Mol Diagn; 2005 Oct; 7(4):544-9. PubMed ID: 16237225
[TBL] [Abstract][Full Text] [Related]
24. A case of subependymal giant cell astrocytoma without tuberous sclerosis complex and review of the literature.
O'Rawe M; Chandran AS; Joshi S; Simonin A; Dyke JM; Lee S
Childs Nerv Syst; 2021 Apr; 37(4):1381-1385. PubMed ID: 32808065
[TBL] [Abstract][Full Text] [Related]
25. Management of subependymal giant cell astrocytoma (SEGA) associated with tuberous sclerosis complex (TSC): Clinical recommendations.
Jóźwiak S; Nabbout R; Curatolo P;
Eur J Paediatr Neurol; 2013 Jul; 17(4):348-52. PubMed ID: 23391693
[TBL] [Abstract][Full Text] [Related]
26. Subependymal giant cell astrocytoma: diagnosis, screening, and treatment. Recommendations from the International Tuberous Sclerosis Complex Consensus Conference 2012.
Roth J; Roach ES; Bartels U; Jóźwiak S; Koenig MK; Weiner HL; Franz DN; Wang HZ
Pediatr Neurol; 2013 Dec; 49(6):439-44. PubMed ID: 24138953
[TBL] [Abstract][Full Text] [Related]
27. Experience using mTOR inhibitors for subependymal giant cell astrocytoma in tuberous sclerosis complex at a single facility.
Tomoto K; Fujimoto A; Inenaga C; Okanishi T; Imai S; Ogai M; Fukunaga A; Nakamura H; Sato K; Obana A; Masui T; Arai Y; Enoki H
BMC Neurol; 2021 Mar; 21(1):139. PubMed ID: 33784976
[TBL] [Abstract][Full Text] [Related]
28. A solitary extraventricular subependymal giant cell astrocytoma in the absence of tuberous sclerosis.
Tompe AP; Sargar KM; Kazmi SAJ; Shimony N
Radiol Case Rep; 2021 Jan; 16(1):180-184. PubMed ID: 33250950
[TBL] [Abstract][Full Text] [Related]
29. Natural History and Current Treatment Options for Subependymal Giant Cell Astrocytoma in Tuberous Sclerosis Complex.
Jóźwiak S; Mandera M; Młynarski W
Semin Pediatr Neurol; 2015 Dec; 22(4):274-81. PubMed ID: 26706014
[TBL] [Abstract][Full Text] [Related]
30. Dose-level response rates of mTor inhibition in tuberous sclerosis complex (TSC) related subependymal giant cell astrocytoma (SEGA).
Weidman DR; Pole JD; Bouffet E; Taylor MD; Bartels U
Pediatr Blood Cancer; 2015 Oct; 62(10):1754-60. PubMed ID: 25929843
[TBL] [Abstract][Full Text] [Related]
31. Congenital subpendymal giant cell astrocytoma in children with tuberous sclerosis complex: growth patterns and neurological outcome.
Chan DL; Kennedy SE; Sarkozy VE; Chung CWT; Flanagan D; Mowat D; Farrar MA; Lawson JA
Pediatr Res; 2021 May; 89(6):1447-1451. PubMed ID: 32516799
[TBL] [Abstract][Full Text] [Related]
32. Dysregulation of the MMP/TIMP Proteolytic System in Subependymal Giant Cell Astrocytomas in Patients With Tuberous Sclerosis Complex: Modulation of MMP by MicroRNA-320d In Vitro.
Bongaarts A; de Jong JM; Broekaart DWM; van Scheppingen J; Anink JJ; Mijnsbergen C; Jansen FE; Spliet WGM; den Dunnen WFA; Gruber VE; Scholl T; Hainfellner JA; Feucht M; Borkowska J; Kotulska K; Jozwiak S; Grajkowska W; Buccoliero AM; Caporalini C; Giordano F; Genitori L; Scicluna BP; Schouten-van Meeteren AYN; van Vliet EA; Mühlebner A; Mills JD; Aronica E
J Neuropathol Exp Neurol; 2020 Jul; 79(7):777-790. PubMed ID: 32472129
[TBL] [Abstract][Full Text] [Related]
33. Subependymal giant cell astrocytoma in the absence of tuberous sclerosis: illustrative case.
Shelley I; Mahtabfar A; Farrell CJ
J Neurosurg Case Lessons; 2023 Jun; 5(25):. PubMed ID: 37354433
[TBL] [Abstract][Full Text] [Related]
34. Tuberous sclerosis complex: genotype/phenotype correlation of retinal findings.
Aronow ME; Nakagawa JA; Gupta A; Traboulsi EI; Singh AD
Ophthalmology; 2012 Sep; 119(9):1917-23. PubMed ID: 22608477
[TBL] [Abstract][Full Text] [Related]
35. The effect of mTOR inhibition on obstructive hydrocephalus in patients with tuberous sclerosis complex (TSC) related subependymal giant cell astrocytoma (SEGA).
Weidman DR; Palasamudram S; Zak M; Whitney R; McCoy B; Bouffet E; Taylor M; Shroff M; Bartels U
J Neurooncol; 2020 May; 147(3):731-736. PubMed ID: 32285309
[TBL] [Abstract][Full Text] [Related]
36. Subependymal Giant Cell Astrocytomas in Tuberous Sclerosis Complex-Current Views on Their Pathogenesis and Management.
Gao C; Zabielska B; Jiao F; Mei D; Wang X; Kotulska K; Jozwiak S
J Clin Med; 2023 Jan; 12(3):. PubMed ID: 36769603
[TBL] [Abstract][Full Text] [Related]
37. Subependymal giant cell astrocytoma with positive tuberin expression--case report.
Tabuchi S; Takigawa H; Oka A; Mizuguchi M; Horie Y; Watanabe T
Neurol Med Chir (Tokyo); 2003 Dec; 43(12):616-8. PubMed ID: 14723270
[TBL] [Abstract][Full Text] [Related]
38. Hemorrhage Into a Subependymal Giant Cell Astrocytoma in an Adult With Tuberous Sclerosis: Case Report.
Barbiero FJ; Huttner AJ; Fulbright RK; Baehring JM
Neurologist; 2021 Jul; 26(4):122-124. PubMed ID: 34190204
[TBL] [Abstract][Full Text] [Related]
39. Bleeding solitary SEGA in non-tuberous sclerosis complex adolescent: a case illustration and review of literature.
Yindeedej V; Rojnueangnit K; Chotsakulthong P; Thamwongskul C
Childs Nerv Syst; 2024 Apr; ():. PubMed ID: 38578478
[TBL] [Abstract][Full Text] [Related]
40. Prevalence of subependymal giant cell tumors in patients with tuberous sclerosis and a review of the literature.
Adriaensen ME; Schaefer-Prokop CM; Stijnen T; Duyndam DA; Zonnenberg BA; Prokop M
Eur J Neurol; 2009 Jun; 16(6):691-6. PubMed ID: 19236458
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
